Among the results not statistically significant, after multiple testing correction, it is worth mentioning three additional proteins considered suggestive, i.e., somatostatin (SST), ceruloplasmin (CP), and tissue type plasminogen activator (PLAT), having a sex- and age-adjusted absolute difference between MS case and healthy control levels of at least 0.30 HC SD with an uncorrected p-value < 0.005. The gene discussed is SST; the disease is myeloid sarcoma.